Voices
Nina Niu Sanford: Defining the Role of SBRT in HCC Among Local Treatment Modalities
Nina Niu Sanford/X

Nina Niu Sanford: Defining the Role of SBRT in HCC Among Local Treatment Modalities

Nina Niu Sanford, Assistant Professor and Chief of Gastrointestinal Radiation Oncology at Harvard/Brigham and Women’s Hospital/Massachusetts General Hospital, shared a post on X:

“How do we define the role of SBRT in HCC amidst many other available local modalities? Do we need a Ph III RCT with OS endpoint?

Thoughts from Laura Dawson, liver SBRT pioneer now s/p after decades of experience leading HCC trials.”

Other articles about SBRT on OncoDaily.

cancer cancer treatment clinical trials evidence based medicine HCC hepatocellular carcinoma Laura Dawson liver cancer Liver Oncology Local Therapy Nina Niu Sanford OncoDaily Oncology oncology research overall survival Phase III trial radiation oncology radiation therapy randomized controlled trial SBRT Stereotactic Body Radiotherapy Treatment Strategy